Literature DB >> 33777141

Association between 25-Hydroxyvitamin D and Metabolic Syndrome in Older Adults: The Health, Aging and Body Composition Study.

Subhashish Agarwal1, Janet A Tooze2, Douglas C Bauer3, Jane A Cauley4, Tamara B Harris5, Annemarie Koster6, Catherine R Womack7, Stephen B Kritchevsky8, Denise K Houston9.   

Abstract

OBJECTIVE: Low 25-hydroxyvitamin D (25[OH]D) levels and metabolic syndrome (MetS) are prevalent among older adults; however, longitudinal studies examining 25(OH)D status and MetS are lacking. We explore the association of 25(OH)D levels with prevalent and incident MetS in white and black older adults. Research Design and Methods. A total of 1620 white and 1016 black participants aged 70-79 years from the Health ABC cohort with measured 25(OH)D levels and data on MetS and covariates of interest were examined. The association between 25(OH)D levels and prevalent MetS at baseline and incident MetS at 6-year follow-up was examined in whites and blacks separately using logistic regression adjusting for demographics, lifestyle factors, and renal function.
RESULTS: At baseline, 635 (39%) white and 363 (36%) black participants had prevalent MetS. In whites, low 25(OH)D levels were associated with prevalent MetS (adjusted OR (95% CI), 1.85 (1.47, 2.34)) and 1.96 (1.46, 2.63) for 25(OH)D of 20-<30 and <20 vs. ≥30 ng/ml, respectively). The association was attenuated after adjustment for BMI but remained significant. No association was found between 25(OH)D levels and prevalent MetS in blacks. Among those without MetS at baseline (765 whites, 427 blacks), 150 (20%) whites and 87 (20%) blacks had developed MetS at 6-year follow-up. However, 25(OH)D levels were not associated with incident MetS in whites or blacks.
CONCLUSION: In older adults, low 25(OH)D levels were associated with increased odds of prevalent MetS in whites but not in blacks. No association was observed between 25(OH)D levels and incident MetS in either whites or blacks.
Copyright © 2021 Subhashish Agarwal et al.

Entities:  

Year:  2021        PMID: 33777141      PMCID: PMC7981173          DOI: 10.1155/2021/6671823

Source DB:  PubMed          Journal:  Int J Endocrinol        ISSN: 1687-8337            Impact factor:   3.257


  34 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Vitamin D intake is inversely related to risk of developing metabolic syndrome in African American and white men and women over 20 y: the Coronary Artery Risk Development in Young Adults study.

Authors:  Grace J Fung; Lyn M Steffen; Xia Zhou; Lisa Harnack; Weihong Tang; Pamela L Lutsey; Catherine M Loria; Jared P Reis; Linda V Van Horn
Journal:  Am J Clin Nutr       Date:  2012-05-30       Impact factor: 7.045

3.  Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults.

Authors:  Earl S Ford; Umed A Ajani; Lisa C McGuire; Simin Liu
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

4.  Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab).

Authors:  Claudia Gagnon; Zhong X Lu; Dianna J Magliano; David W Dunstan; Jonathan E Shaw; Paul Z Zimmet; Ken Sikaris; Peter R Ebeling; Robin M Daly
Journal:  J Clin Endocrinol Metab       Date:  2012-03-22       Impact factor: 5.958

5.  Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults.

Authors:  Jared P Reis; Denise von Mühlen; Donna Kritz-Silverstein; Deborah L Wingard; Elizabeth Barrett-Connor
Journal:  Diabetes Care       Date:  2007-03-10       Impact factor: 19.112

Review 6.  Effectiveness and safety of calcium and vitamin D treatment for postmenopausal osteoporosis.

Authors:  R Cesareo; M Iozzino; L D'onofrio; I Terrinoni; E Maddaloni; A Casini; G Campagna; A Santonati; A Palermo
Journal:  Minerva Endocrinol       Date:  2015-09       Impact factor: 2.184

7.  Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction.

Authors:  Ken C Chiu; Audrey Chu; Vay Liang W Go; Mohammed F Saad
Journal:  Am J Clin Nutr       Date:  2004-05       Impact factor: 7.045

8.  Frequency of leisure-time physical activity and serum 25-hydroxyvitamin D levels in the US population: results from the Third National Health and Nutrition Examination Survey.

Authors:  Robert Scragg; Carlos A Camargo
Journal:  Am J Epidemiol       Date:  2008-06-25       Impact factor: 4.897

Review 9.  Controversies in Vitamin D: A Statement From the Third International Conference.

Authors:  Andrea Giustina; Roger Bouillon; Neil Binkley; Christopher Sempos; Robert A Adler; Jens Bollerslev; Bess Dawson-Hughes; Peter R Ebeling; David Feldman; Annemieke Heijboer; Glenville Jones; Christopher S Kovacs; Marise Lazaretti-Castro; Paul Lips; Claudio Marcocci; Salvatore Minisola; Nicola Napoli; Rene Rizzoli; Robert Scragg; John H White; Anna Maria Formenti; John P Bilezikian
Journal:  JBMR Plus       Date:  2020-11-10

10.  Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals.

Authors:  Ling Lu; Zhijie Yu; An Pan; Frank B Hu; Oscar H Franco; Huaixing Li; Xiaoying Li; Xilin Yang; Yan Chen; Xu Lin
Journal:  Diabetes Care       Date:  2009-04-14       Impact factor: 17.152

View more
  1 in total

1.  Prevalence of vitamin D deficiency and its association with metabolic syndrome among the elderly population of Birjand, Iran.

Authors:  Fatemeh Hoseinzadeh-Chahkandak; Tayebeh Zeinali; Fatemeh Salmani; Mitra Moodi; Farshad Sharifi; Mehran Rahimlou; Elham Ansarifar
Journal:  J Diabetes Metab Disord       Date:  2022-02-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.